Clinical Trial

Acceptance and Commitment Therapy for Adolescents and Young Adults With Sickle Cell Disease

Study acronym: ACT for SCD
Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
The current study seeks to build on previous research that demonstrates the efficacy of Acceptance and Commitment Therapy in combating stigma by investigating the feasibility and acceptability of a protocol to support Black adolescents and young adults in coping with race related stress. The study will consist of a small, purposeful, non-randomized sample (N = 30) of clients enrolled into a 10-session Acceptance and Commitment Therapy group. The group will be offered as part of regular clinical care at the Division of Adolescent and Young Adult Medicine. Three consecutive groups will be run with approximately 8-10 participants in each group over the next year.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2023-01-05; most recent amendment 2026-04-30.
Status change: Not Yet Recruiting → Recruiting 2023-11-03
Trial Details
NCT Number NCT05685368
Lead Sponsor Children's Hospital Los Angeles
Collaborators: University of Southern California & Children's Hospital Los Angeles (USC-CHLA)
Conditions Race-related Stress, Depression, Anxiety, Quality of Life, Stress Reaction
Enrollment 66 participants
Start Date 2025-04-01
Primary Completion 2029-06-30 (estimated)
Study Completion 2029-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-06